Small volume bone marrow aspirates with high progenitor cell concentrations maximize cell therapy dose manufacture and substantially reduce donor hemoglobin loss.
Saved in:
| Title: | Small volume bone marrow aspirates with high progenitor cell concentrations maximize cell therapy dose manufacture and substantially reduce donor hemoglobin loss. |
|---|---|
| Authors: | Epah, Jeremy1 (AUTHOR), Spohn, Gabriele1 (AUTHOR), Preiß, Kathrin1 (AUTHOR), Müller, Markus M.1 (AUTHOR), Dörr, Johanna1 (AUTHOR), Bauer, Rainer1 (AUTHOR), Daqiq-Mirdad, Shabnam1 (AUTHOR), Schwäble, Joachim1 (AUTHOR), Bernas, Stefanie N.2 (AUTHOR), Schmidt, Alexander H.2 (AUTHOR), Seifried, Erhard1 (AUTHOR), Schäfer, Richard1,3 (AUTHOR) richard.schaefer@uniklinik-freiburg.de |
| Source: | BMC Medicine. 9/19/2023, Vol. 21 Issue 1, p1-16. 16p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 17417015 |
|---|---|
| DOI: | 10.1186/s12916-023-03059-3 |
